Press Releases from DelveInsight (681 total)
Post-Polycythemia Vera Myelofibrosis Clinical Trials Analysis 2025: Novel JAK In …
DelveInsight's "Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Clinical Trials Analysis, 2025" highlights an evolving pipeline designed to tackle the limitations of current therapies and improve long-term…
Immunologic Deficiency Syndrome Clinical Trials Analysis 2025: Gene Therapies, N …
DelveInsight's "Immunologic Deficiency Syndrome - Clinical Trials Analysis, 2025" reviews the rapidly evolving clinical landscape for primary and selected secondary immunodeficiency disorders, a heterogeneous group…
Vestibular Schwannoma Clinical Trials Analysis 2025: Hearing-Preservation Strate …
DelveInsight's "Vestibular Schwannoma - Clinical Trials Analysis, 2025" examines the evolving clinical-trial landscape for vestibular schwannoma (VS). This typically benign cranial nerve tumor can cause…
Diabetic Foot Ulcers Pipeline Insight 2025: 25+ Regenerative, Antimicrobial, and …
DelveInsight's "Diabetic Foot Ulcers - Pipeline Insight, 2025" survey examines more than 25 therapies in development that address diabetic foot ulcers (DFUs), a leading cause…
Attention Deficit Hyperactivity Disorder Clinical Trials Analysis 2025: Novel Me …
DelveInsight's "Attention Deficit Hyperactivity Disorder (ADHD) - Clinical Trials Analysis, 2025" reviews an evolving pipeline focused on enhancing symptom control, reducing side effects, and improving…
Motor Neuron Disease Pipeline Insight 2025: Gene-Targeted Therapies, Neuroprotec …
DelveInsight's "Motor Neuron Disease - Pipeline Insight, 2025" highlights 200+ therapies in development for ALS and related motor neuron disorders. Despite supportive care being the…
Herpes Labialis Clinical Pipeline Insight 2025: Antivirals, Vaccines, and Long-A …
DelveInsight's "Herpes Labialis - Clinical Pipeline Insight, 2025" reviews more than 6+ therapies in development for herpes labialis (cold sores), a recurrent infection most commonly…
Microbiome Disease Pipeline Insight 2025: 180+ Pipeline Drugs, Live Biotherapeut …
DelveInsight's "Microbiome Disease - Pipeline Insight, 2025" covers over 180+ therapies in development targeting microbiome-associated diseases across diverse therapeutic areas, including gastrointestinal, metabolic, dermatological, neurological,…
Renal Cancer Clinical Trials Analysis 2025: Next-Generation Targeted Therapies a …
DelveInsight's "Renal Cancer - Clinical Trials Analysis, 2025" explores the rapidly evolving therapeutic landscape for renal cell carcinoma (RCC), the most common form of kidney…
Polymyositis Clinical Trial Analysis 2025: How Emerging Therapies Are Shaping th …
DelveInsight's "Polymyositis - Pipeline Insight, 2025" examines the evolving therapeutic landscape for polymyositis, a rare autoimmune inflammatory myopathy characterized by progressive muscle weakness and systemic…
Ulcerative Colitis Clinical Trials Analysis 2025: Advancing Biologics, Small Mol …
DelveInsight's "Ulcerative Colitis - Clinical Trials Analysis, 2025" reviews the expanding landscape of therapies in development for ulcerative colitis (UC), a chronic inflammatory bowel disease…
Amyloid Light-Chain Amyloidosis Clinical Trials Analysis 2025: Emerging Therapie …
DelveInsight's "Amyloid Light-Chain (AL) Amyloidosis - Clinical Trials Analysis, 2025" examines the evolving therapeutic landscape for Amyloid Light-Chain Amyloidosis, a rare and life-threatening disorder characterized…
Psoriatic Arthritis Clinical Trials Analysis 2025: Expanding Biologics, Small Mo …
DelveInsight's "Psoriatic Arthritis - Clinical Trials Analysis, 2025" highlights the dynamic evolution of the therapeutic landscape for psoriatic arthritis (PsA), a chronic immune-mediated inflammatory arthritis…
Ischemic Stroke Clinical Trials 2025: Tenecteplase FDA Approval, Thrombectomy Up …
DelveInsight's "Ischemic Stroke - Clinical Trials, 2025" captures a rapidly evolving landscape in which improvements in acute reperfusion (thrombolysis and endovascular thrombectomy), adjunctive neuroprotection, and…
Attention Deficit Hyperactivity Disorder Clinical Trials 2025: 22+ Pipeline Ther …
DelveInsight's "Attention Deficit Hyperactivity Disorder - Clinical Trials, 2025" reviews over 22 therapies in development for ADHD, a highly prevalent neurodevelopmental disorder affecting both children…
Chronic Heart Failure Clinical Trials 2025: 25+ Pipeline Therapies, SGLT2 Inhibi …
DelveInsight's "Chronic Heart Failure - Clinical Trials, 2025" highlights 25+ therapies in development for CHF, a progressive condition marked by high morbidity and mortality. Beyond…
Beta-Thalassemia Clinical Trials 2025: 22+ Pipeline Therapies, Gene Editing, and …
DelveInsight's "Beta-Thalassemia - Clinical Trials, 2025" reviews over 22 therapies in development for beta-thalassemia, a rare inherited blood disorder characterized by impaired hemoglobin production and…
Atopic Dermatitis Clinical Trials 2025: Incyte Announces Additional FDA Approval …
DelveInsight's "Atopic Dermatitis - Clinical Trials, 2025" reviews 90+ therapies currently in development for atopic dermatitis, a chronic inflammatory skin condition that imposes a high…
Moderate to Severe Inflammatory Acne Vulgaris Clinical Trials, 2025: 15+ Pipelin …
DelveInsight's "Moderate to Severe Inflammatory Acne Vulgaris - Clinical Trials, 2025" reviews 15+ therapies in development for acne vulgaris, a chronic dermatologic disease marked by…
Parkinson's Disease Pipeline Insight 2025: 100+ Pipeline Drugs, Gene, Cell, and …
DelveInsight's "Parkinson's Disease - Pipeline Insight, 2025" surveys a robust and fast-moving pipeline of 100+ investigational therapies spanning small molecules, biologics, gene, and cell therapies.…
Mitochondrial Myopathies Pipeline Insight 2025: Advancing Novel Therapeutics for …
DelveInsight's "Mitochondrial Myopathies - Pipeline Insight, 2025" explores the evolving landscape of therapies in development for mitochondrial myopathies, a group of rare, progressive neuromuscular disorders…
Metastatic Melanoma Clinical Trials 2025: 75+ Pipeline Drugs, Targeted Therapies …
DelveInsight's "Metastatic Melanoma - Clinical Trials, 2025" reviews 75+ therapies currently in development for metastatic melanoma, one of the most aggressive forms of skin cancer…
Multiple System Atrophy Pipeline Insight 2025: 22+ Pipeline Drugs, Disease-Modif …
DelveInsight's "Multiple System Atrophy (MSA) - Pipeline Insight, 2025" reviews a growing portfolio of 22+ therapies in development for MSA, a rare, rapidly progressive neurodegenerative…
Hepatocellular Carcinoma Pipeline Insight 2025: 95+ Pipeline Drugs, Targeted Age …
DelveInsight's "Hepatocellular Carcinoma - Pipeline Insight, 2025" explores over 95+ therapies in development for hepatocellular carcinoma (HCC), the most common form of primary liver cancer…
Insulin Resistance Pipeline Insight 2025: Pipeline Drugs, Metabolic Pathway Modu …
DelveInsight's "Insulin Resistance - Pipeline Insight, 2025" explores over 10+ therapies in development for insulin resistance, a metabolic condition strongly linked to type 2 diabetes,…
Uveal Melanoma Pipeline Insight 2025: 30+ Pipeline Drugs, Targeted Therapies, an …
DelveInsight's "Uveal Melanoma - Pipeline Insight, 2025" explores over 30+ therapies in development for uveal melanoma, a rare and aggressive intraocular malignancy with high metastatic…
Peptic Ulcers Pipeline Insight 2025: Emerging Therapies and Clinical Trials Shap …
DelveInsight's "Peptic Ulcers - Pipeline Insight, 2025" examines over 8+ therapies in development for peptic ulcer disease, a condition affecting millions worldwide with peptic ulcer…
Vaso-Occlusive Crisis in Sickle Cell Disease: Emerging Therapies, Clinical Trial …
DelveInsight's "Vaso-Occlusive Crisis (VOC) Associated With Sickle Cell Disease - Pipeline Insight, 2025" provides an in-depth analysis of emerging therapies targeting vaso-occlusive crisis (VOC), a…
Pemphigus Vulgaris Clinical Trials 2025: Emerging Therapies, Key Players, and Tr …
DelveInsight's "Pemphigus Vulgaris - Pipeline Insight, 2025" provides a comprehensive overview of the evolving treatment landscape for pemphigus vulgaris, a rare, chronic, and potentially life-threatening…
Peripheral Arterial Clinical Trial Analysis 2025: 22+ Emerging Therapies, Novel …
DelveInsight's "Peripheral Arterial Disease - Pipeline Insight, 2025" explores over 22+ therapies in development for peripheral arterial disease (PAD), a chronic and progressive condition caused…
Ovarian Cancer Clinical Trial Analysis 2025: 200+ Pipeline Drugs, PARP Inhibitor …
DelveInsight's "Ovarian Cancer - Pipeline Insight, 2025" reviews over 200+ therapies in development for ovarian cancer, one of the most challenging gynecologic malignancies with high…
HER2-Positive Breast Cancer Pipeline Insight 2025: 55+ Pipeline Drugs, Targeted …
DelveInsight's "HER2-Positive Breast Cancer - Pipeline Insight, 2025" highlights over 55+ therapies in development for HER2-positive breast cancer, one of the most aggressive breast cancer…
Focal Segmental Glomerulosclerosis Pipeline Insight 2025: 18+ Emerging Therapies …
DelveInsight's "Focal Segmental Glomerulosclerosis - Pipeline Insight, 2025" reviews more than 18+ therapies in development for focal segmental glomerulosclerosis (FSGS), a rare and severe form…
Non-Muscle Invasive Bladder Cancer Pipeline Insight 2025: 22+ Emerging Therapies …
DelveInsight's "Non-Muscle Invasive Bladder Cancer - Pipeline Insight, 2025" highlights more than 22+ therapies in development for non-muscle invasive bladder cancer (NMIBC). In this prevalent…
Leishmaniasis Pipeline Insight 2025: Emerging Drugs, Novel Antiparasitic Approac …
DelveInsight's "Leishmaniasis - Pipeline Insight, 2025" highlights over 3+ drugs in development for leishmaniasis, a neglected tropical disease caused by Leishmania parasites and transmitted through…
Liposarcoma Pipeline Insight 2025: 15+ Pipeline Drugs, Targeted Therapies, and I …
DelveInsight's "Liposarcoma - Pipeline Insight, 2025" explores over 15+ therapies in development for liposarcoma, a rare and heterogeneous soft tissue sarcoma subtype. Despite surgery and…
Type 1 Diabetes Pipeline Insight 2025: 100+ Pipeline Drugs, Cell Therapies, and …
DelveInsight's "Type 1 Diabetes - Pipeline Insight, 2025" explores the fast-evolving pipeline of more than 100+ therapies in development for type 1 diabetes (T1D), an…
Atrial Fibrillation Pipeline Insight 2025: 15+ Pipeline Drugs, Gene Therapies, a …
DelveInsight's "Atrial Fibrillation - Pipeline Insight, 2025" examines more than 15+ therapies in development for atrial fibrillation (AF), the most common sustained cardiac arrhythmia associated…
TIL Therapy Pipeline Insight 2025: Harnessing Tumor-Infiltrating Lymphocytes to …
DelveInsight's "TIL Therapy - Pipeline Insight, 2025" provides an in-depth look at the rapidly expanding field of tumor-infiltrating lymphocyte (TIL) therapy, an adoptive cell therapy…
Norovirus Infection Pipeline Insight 2025: Advancing Antivirals and Vaccines to …
DelveInsight's "Norovirus Infection - Pipeline Insight, 2025" provides a comprehensive overview of the emerging therapies targeting norovirus, a highly contagious pathogen responsible for acute gastroenteritis…
Klebsiella Infections Pipeline Insight 2025: Innovative Antibiotics and Novel Th …
DelveInsight's "Klebsiella Infections - Pipeline Insight, 2025" explores the evolving landscape of therapies aimed at tackling Klebsiella pneumoniae and related species, which are major culprits…
Vancomycin Resistant Enterococcal Infections Pipeline Insight 2025: Novel Antibi …
DelveInsight's "Vancomycin Resistant Enterococcal (VRE) Infections - Pipeline Insight, 2025" highlights the evolving treatment landscape for one of the most pressing antimicrobial resistance (AMR) threats.…
Type 2 Diabetes Pipeline Insight 2025: Next-Gen Incretins, Gene Therapies, and M …
DelveInsight's "Type 2 Diabetes - Pipeline Insight, 2025" explores the evolving pipeline for type 2 diabetes (T2D), a chronic disorder marked by insulin resistance and…
Wet Age-Related Macular Degeneration Pipeline Insight 2025: Over 60+ Companies A …
DelveInsight's "Wet-AMD - Pipeline Insight, 2025" maps a fast-moving landscape for neovascular (wet) age-related macular degeneration, a leading cause of vision loss driven by choroidal…
Pulmonary Embolism Pipeline Insight 2025: Novel Anticoagulants, Thrombolytics, a …
DelveInsight's "Pulmonary Embolism - Pipeline Insight, 2025" explores the advancing treatment landscape for pulmonary embolism, a life-threatening condition resulting from obstruction of the pulmonary arteries,…
Immune Thrombocytopenia Clinical Trials 2025: Advancing TPO-R Agonists, FcRn Blo …
DelveInsight's "Immune Thrombocytopenia (ITP) - Pipeline Insight, 2025" highlights the rapidly evolving therapeutic landscape for ITP, an autoimmune bleeding disorder characterized by accelerated platelet destruction…
Graft Preparation System Market to Register a CAGR of 4.17% by 2032, Driven by R …
The graft preparation system market is anticipated to grow steadily, fueled by the increasing prevalence of orthopedic disorders, sports injuries, and cardiovascular diseases that demand…
High-Throughput Screening Market to Register a CAGR of 10.61% by 2032, Driven by …
The high-throughput screening (HTS) market is set for significant growth, driven by the increasing demand for rapid drug discovery, rising investment in pharmaceutical research, and…
Healthcare Asset Management Market to Register a CAGR of 19.27% by 2032, Driven …
The healthcare asset management market is expected to experience significant growth, driven by rising investments in healthcare infrastructure, the increasing complexity of hospital equipment management,…
In Situ Hybridization Market to Register a CAGR of 7.12% by 2032, Driven by Risi …
The in situ hybridization (ISH) market is poised for substantial growth, fueled by the increasing demand for precision diagnostics, rising prevalence of cancer and genetic…
